Pernix Therapeutics

Pernix Therapeutics

Employees:
190
Market Cap:
$34.88 million
Revenue:
$140.93 million
5 Year Trend:
18.3%
Net Income:
$-167.59 million
NASDAQ:
PTX

Pernix Therapeutics (NASDAQ: PTX) is a specialty pharmaceutical business with a focus on acquiring, developing and commercializing prescription drugs primarily for the U.S. market. The Company targets underserved therapeutic areas such as CNS, including neurology and psychiatry, and has an interest in expanding into additional specialty segments. Wikipedia

Pernix Therapeutics

Pernix Therapeutics (NASDAQ: PTX) is a specialty pharmaceutical business with a focus on acquiring, developing and commercializing prescription drugs primarily for the U.S. market. The Company targets underserved therapeutic areas such as CNS, including neurology and psychiatry, and has an interest in expanding into additional specialty segments. Wikipedia

Employees:
190
Market Cap:
$34.88 million
Revenue:
$140.93 million
5 Year Trend:
18.3%
Net Income:
$-167.59 million
NASDAQ:
PTX

6 jobs at Pernix Therapeutics

Jobs in